[1] European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases[J]. Hepatol,2009,51(2):237-267.
[2] Isse K, Harada K, Sato Y, et al. Characterization of biliary intra-epithelial lymphocytes at different anatomical levels of intrahepatic bile ducts under normal and pathological conditions: numbers of CD4+CD28-intra-epithelial lymphocytes are increased in primary biliary cirrhosis[J]. Pathol Int., 2006,56(1):17-24.
[3] 高峰,贾继东. 熊去氧胆酸治疗原发性胆汁性肝硬化的研究进展[J]. 胃肠病学与肝病学杂志,2004,13(5):562-565.
[4] Ali AH, Carey EJ,Lindor KD. Diagnosis and management of primary biliary cirrhosis[J]. Expert Rev Clin Immunol, 2014,10(12):1667-1678.
[5] 付德才,华忠,李焱光,等. 清营活血汤联合熊去氧胆酸胶囊治疗早、中期原发性胆汁性肝硬化临床疗效观察[J]. 中国中西医结合杂志,2015,35(3):290-293.
[6] Lammers WJ, van Buuren HR, Hirschfield GM, et al. Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study[J]. Gastroenterology,2014,147(6):1338-1349.
[7] Untas A, Boujut E, Corpechot C, et al. Quality of life and illness perception in primary biliary cirrhosis: a controlled cross-sectional study[J]. Clin Res Hepatol Gastroenterol, 2015,39(1):52-58.
[8] Aso-Ishimoto Y, Yamagiwa S, Ichida T, et al.Increased activated natural killer T cells in the liver of patients with advanced stage primary biliary cirrhosis[J]. Biomed Res, 2014,35(2):161-169.
[9] 曹雯,许道龙,吴万哈,等. 复方水牛角提取物镇痛、抗炎作用的实验研究[J]. 药学服务与研究,2011,11(2):103-106.
[10] 黄盛勇,吴勇杰. 丹参的抗氧化与抗炎作用研究进展[J]. 中国中医药信息杂志,2002,9(1):86-89.
[11] 胡竟一,雷玲,余悦,等. 连翘的抗炎解热作用研究[J]. 中药药理与临床,2007,23(3):51-54.
[12] 王利津,徐强. 黄连解毒汤的抗炎作用机理研究[J]. 中国中药杂志,2000,25(8):493-496.
[13] Smyk DS, Mytilinaiou MG, Grammatikopoulos T, et al. Primary biliary cirrhosis-specific antimitochondrial antibodies in neonatal haemochromatosis[J]. Clin Dev Immunol, 2013,20(13):642-643.
[14] Papastergiou V, Tsochatzis EA, Rodriquez-Peralvarez M, et al. Biochemical criteria at 1 year are not robust indicators of response to ursodeoxycholic acid in early primary biliary cirrhosis: results from a 29-year cohort study[J]. Aliment Pharmacol Ther, 2013, 38(11-12):1354-64.
[15] Sakaguchi S, Sakaguchi N, Shimizu J, et al. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance[J]. Immunol Rev, 2001,182:18-32.